TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ:200230)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,885.00
+165.00 (4.44%)
May 13, 2025, 3:30 PM KST
-52.33%
Market Cap 46.72B
Revenue (ttm) 37.87B
Net Income (ttm) -26.32B
Shares Out 12.03M
EPS (ttm) -2,225.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 24,362
Average Volume 78,378
Open 3,615.00
Previous Close 3,720.00
Day's Range 3,615.00 - 3,895.00
52-Week Range 2,855.00 - 9,300.00
Beta 0.83
RSI 54.95
Earnings Date May 12, 2025

About TELCON RF PHARMACEUTICAL.

TELCON RF PHARMACEUTICAL. Inc. primarily engages in the development, production, and sale of RF coaxial connectors worldwide. It also provides coaxial couplers, distributors, and arresters, as well as cable assemblies; and pharmaceuticals. The company was formerly known as Telcon Co., Ltd. TELCON RF PHARMACEUTICAL. Inc. was founded in 1999 and is headquartered in Yongin-si, South Korea. [Read more]

Sector Technology
Founded 1999
Employees 127
Stock Exchange KOSDAQ
Ticker Symbol 200230
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.